Ribonucleoside cyclic acetal derivatives for the treatment of RNA-dependent RNA viral infection

Details for Australian Patent Application No. 2006280175 (hide)

Owner Merck Sharp & Dohme Corp.

Inventors Butora, Gabor; Olsen, David B.; McMasters, Daniel R.; Yang, Lihu; MacCoss, Malcolm; Koeplinger, Kenneth Alan

Agent Spruson & Ferguson

Pub. Number AU-B-2006280175

PCT Pub. Number WO2007/021610

Priority 60/706,708 09.08.05 US

Filing date 4 August 2006

Wipo publication date 22 February 2007

Acceptance publication date 1 September 2011

International Classifications

C07H 19/00 (2006.01) Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical

A01N 43/04 (2006.01) Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds

A01N 57/00 (2006.01) Biocides, pest repellants or attractants, or plant growth regulators containing organic phosphorus compounds

A61K 31/519 (2006.01) - ortho- or peri-condensed with heterocyclic rings

Event Publications

6 March 2008 PCT application entered the National Phase

  PCT publication WO2007/021610 Priority application(s): WO2007/021610

28 January 2010 Alteration of Name

  The name of the applicant has been altered to Merck Sharp & Dohme Corp.

1 September 2011 Application Accepted

  Published as AU-B-2006280175

12 January 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006280176-Composite materials including high modulus polyolefin fibers and method of making same

2006280168-Methods and compositions for soothing oral and nasal tissues